Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline to Treat Amyotrophic Lateral Sclerosis
NCT00047723Phase 3Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in amyotrophic lateral sclerosis (ALS), sponsored by National Institute of Neurological Disorders and Stroke. Started Jan 2003; status: completed.
02
Drugs
minocycline
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00047723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047723.